HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Company Registration Number:
11969034 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2024

Period of accounts

Start date: 01 May 2023

End date: 30 April 2024

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Contents of the Financial Statements

for the Period Ended 30 April 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Company Information

for the Period Ended 30 April 2024




Director: FARRUKH SHAH
Registered office: 6
Penwerris Avenue
Isleworth
England
TW7 4QX
Company Registration Number: 11969034 (England and Wales)

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Directors' Report Period Ended 30 April 2024

The directors present their report with the financial statements of the company for the period ended 30 April 2024

Principal Activities

teaching and support of clinical trials

Political and charitable donations

none

Company policy on the employment of disabled persons

equal opportunities employer

Directors

The directors shown below have held office during the whole of the period from 01 May 2023 to 30 April 2024
FARRUKH SHAH

This report was approved by the board of directors on 28 January 2025
And Signed On Behalf Of The Board By:

Name: FARRUKH SHAH
Status: Director

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Profit and Loss Account

for the Period Ended 30 April 2024


2024
£

2023
£
Turnover 33,979 90,312
Other Income 600 5,147
Staff Costs ( 42,680 ) ( 39,830 )
Other charges ( 7,593 ) ( 14,791 )
Tax on Profit - ( 7,759 )
Profit or (Loss) for Period ( 15,694 ) 33,079

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Balance sheet

As at 30 April 2024


2024
£

2023
£
Current assets: 17,385 33,079
Net current assets (liabilities): 17,385 33,079
Total assets less current liabilities: 17,385 33,079
Total net assets (liabilities): 17,385 33,079
Capital and reserves: 17,385 33,079

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Balance sheet continued

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 28 January 2025
And Signed On Behalf Of The Board By:

Name: FARRUKH SHAH
Status: Director

The notes form part of these financial statements

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Employee Information

    Average number of employees: 3

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Off balance sheet disclosure

    No

HAEMOGLOBINOPATHY CONSULTANCY SERVICES LTD.

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 3. Commitments by way of guarantee

    none